Idiopathic Nephrotic Syndrome clinical trials

Explore recruiting idiopathic nephrotic syndrome clinical trials.

Recruiting idiopathic nephrotic syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Idiopathic Nephrotic Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Obinutuzumab Treatment in Frequently Relapsing and Rituximab-Dependent Idiopathic Nephrotic Syndrome in Adults: a fully academic, single-arm, open, prospective, intervention trial

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase III, International, Multicenter, Randomised Open Label Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Patients With Childhood Onset Idiopathic Nephrotic Syndrome

Poland, Germany, Belgium, Italy, Spain, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

OBIRINS - Efficacy and Safety of Obinutuzumab versus Rituximab in childhood Steroid Dependant and Frequent Relapsing Nephrotic Syndrome : à double-blind multicenter randomized controlled study

France

Phase II and Phase III (Integrated) EU CTIS Study details

Early rituximab treatment in children with idiopathic nephrotic syndrome Eng. ERICONS - Early RITUXIMAB in Childhood Onset Nephrotic Syndrome

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prevention of relapse with Levamisole as adjuvant therapy to corticosteroids in children with first episode of idiopathic nephrotic syndrome

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Idiopathic Nephrotic Syndrome trials by city

Idiopathic Nephrotic Syndrome in Toronto Idiopathic Nephrotic Syndrome in Vancouver Idiopathic Nephrotic Syndrome in Montreal Idiopathic Nephrotic Syndrome in Calgary Idiopathic Nephrotic Syndrome in Edmonton Idiopathic Nephrotic Syndrome in Ottawa Idiopathic Nephrotic Syndrome in Winnipeg Idiopathic Nephrotic Syndrome in Quebec City Idiopathic Nephrotic Syndrome in Hamilton Idiopathic Nephrotic Syndrome in Kitchener Idiopathic Nephrotic Syndrome in London Idiopathic Nephrotic Syndrome in Halifax Idiopathic Nephrotic Syndrome in New York Idiopathic Nephrotic Syndrome in Los Angeles Idiopathic Nephrotic Syndrome in Chicago Idiopathic Nephrotic Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease